Kunio Hayashi
Overview
Explore the profile of Kunio Hayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hayashi K, Ikegame K, Takahashi N
Case Rep Hematol
. 2021 May;
2021:5518727.
PMID: 34055427
In the era of tyrosine kinase inhibitor (TKI) treatment, its effectiveness in treating chronic myelogenous leukemia (CML) has been improved, ensuring the same prognosis as that of healthy people of...
2.
Sakai K, Kuwana M, Tanaka H, Hosomichi K, Hasegawa A, Uyama H, et al.
Blood
. 2020 Apr;
135(26):2413-2419.
PMID: 32253422
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare autoimmune disorder caused by neutralizing anti-ADAMTS13 autoantibodies. In white individuals, HLA allele DRB1*11 is a predisposing factor for iTTP, whereas DRB1*04 is...
3.
Nomura S, Konishi A, Tsubokura Y, Azuma Y, Hotta M, Yoshimura H, et al.
Transpl Immunol
. 2019 Nov;
57:101247.
PMID: 31666188
We investigated the effects of early recombinant thrombomodulin (rTM) treatment on long-term prognosis after hematopoietic stem cell transplantation (HSCT). Subjects included 300 patients who underwent allogeneic HSCT (131 in the...
4.
Nomura S, Ito T, Katayama Y, Ota S, Hayashi K, Fujita S, et al.
Transpl Immunol
. 2018 Dec;
53:28-33.
PMID: 30543860
Background: Conditioning chemotherapies for hematopoietic stem cell transplantation (HSCT), especially those that include total body irradiation, can result in serious complications such as graft-versus-host disease (GVHD). Human leukocyte antigen G...
5.
Onaka S, Hayashi K
Scanning
. 2017 Nov;
2017:4893956.
PMID: 29109815
The logarithm ln of rotation matrix is a skew symmetric tensor consisting of three independent elements of real numbers. In addition to the Euler angles and the axis/angle pair, the...
6.
Nomura S, Maeda Y, Ishii K, Katayama Y, Yagi H, Fujishima N, et al.
J Blood Med
. 2016 Feb;
7:1-4.
PMID: 26848281
Background: Conditioning regimens including total body irradiation (TBI) or cyclophosphamide can mobilize high-mobility group box 1 (HMGB1) to peripheral blood. Additionally, increased plasminogen activator inhibitor (PAI)-1 levels are associated with...
7.
Hayashi K, Hattori K, Toi F
Int J Hematol
. 2010 Apr;
91(4):725-7.
PMID: 20390387
No abstract available.
8.
Nomura S, Kurata Y, Tomiyama Y, Takubo T, Hasegawa M, Saigo K, et al.
Clin Appl Thromb Hemost
. 2009 Dec;
16(6):622-7.
PMID: 19959489
Immune thrombocytopenic purpura (ITP) is an acquired hemorrhage condition involving accelerated platelet consumption caused by antiplatelet autoantibodies. Although various therapeutic strategies are used to treat patients with ITP, the standard...
9.
Ishii K, Urase F, Nagare Y, Kimura H, Manabe M, Yagi T, et al.
Arch Gerontol Geriatr
. 2009 Nov;
51(2):209-15.
PMID: 19926148
CHOP (cyclophosphamide, adriamycin, vincristine, and prednisolone) plus rituximab is a standard chemotherapy used to treat patients with aggressive B-cell non-Hodgkin lymphoma (B-NHL). However, among elderly patients, this regimen has not...
10.
Nomura S, Ishii K, Shimizu M, Inami N, Uoshima N, Urase F, et al.
Transpl Immunol
. 2009 Jul;
21(1):23-6.
PMID: 19565673
Endothelial monocyte-activating polypeptide-II (EMAP-II) appears to play an important role in neovascularization and endothelial abnormalities. However, the role of EMAP-II in development of graft-versus-host disease (GVHD) after allogeneic SCT is...